Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 44.49m |
Free float | 43.67m |
P/E (TTM) | 16.23 |
Market cap | 15.71bn USD |
EPS (TTM) | 21.75 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
- United Therapeutics Corporation to Present at Upcoming Investor Conferences
- United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
- United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
- United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
- United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
More ▼